Recruiting
Phase 2

Intravenous Iron in Combination with Standard of Care Immunotherapy in Melanoma

Sponsor:

Indiana University

Code:

NCT06508827

Conditions

Anemia, Iron Deficiency

Melanoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Iron dextran 1000 mg IV

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information